Regional Cancer Center Consortium Annual Meetings

描述（由申请人提供）：资金要求提供部分会议支持的年度会议的“区域癌症中心联盟。“下一届年会将于2006年2月16日至18日在匹兹堡大学医学中心希尔曼癌症中心举行，随后的会议将轮流在其他成员机构举行。 区域癌症中心联盟由来自宾夕法尼亚州、西弗吉尼亚州、俄亥俄州、纽约和密歇根州综合和区域癌症中心的一组实验室和临床研究人员组成。 我们以前的会议（过去8年每年举行一次）取得了成功，人们对继续和改进这一努力产生了热情，这促使我们寻求NCI的支持。 未来五年的支持将极大地帮助我们开发和维持一个独特的，高质量的科学计划，重点围绕重要的，及时的主题，涉及新的疗法和转化研究。 这样的计划将1）加强附近癌症中心之间的区域临床和科学合作; 2）为研究人员、临床医生、行业代表、学生/研究员提供低成本、易于获得但最先进的教育机会。和患者。 NCI的资金将专门用于在今后几年的早期阶段加强会议规划，为研究生/医学生和实验室/临床研究员提供参加会议的机会（通过旅行奖），并帮助支付与联合会区域以外的受邀专家的旅行和会议所用教材（笔记本/幻灯片讲义）有关的费用。 对该联合会的共同组织者来说，至关重要的是让代表性不足的少数群体和妇女参与会议发展的各个阶段，作为发言者和共同组织者，并确保所有人，包括残疾人都能参加会议。 总之，NCI为这次年会提供的资金可以帮助为该国该地区（包括服务不足的农村和城市社区）的癌症研究人员和护理提供者提供长期稳定的重要和独特的教育机会，并大大有助于实现NCI的“路线图”目标，即加强区域和综合癌症中心之间的合作。 该联盟具有巨大的潜力，可以帮助该地区的癌症中心成员建立网络，加强合作努力，并在癌症治疗方面试行创新方法，特别是新的生物或免疫方法，这将最终有利于患者护理和及时完成新的临床试验。

DESCRIPTION (provided by applicant): Funds are requested to provide partial meeting support for the annual meetings of the "Regional Cancer Center Consortium." The next annual meeting is being held Feb. 16-18th, 2006 at the Hillman Cancer Center at the University of Pittsburgh Medical Center and subsequent meetings will rotate to other member Institutions. The Regional Cancer Center Consortium is composed of a group of laboratory and clinical investigators from Comprehensive and Regional Cancer Centers in Pennsylvania, West Virginia, Ohio, New York, and Michigan. The success of our prior meetings (held annually for the past 8 years) and the enthusiasm that has been generated for continuing and improving this effort has now prompted us to seek NCI support. Support for the next five years will greatly help us to develop and sustain a unique, high quality scientific program focused around important, timely themes concerning novel therapies and translational research. Such a program will 1) enhance regional clinical and scientific collaborations among near-by cancer centers and 2) provide a low cost and easily accessible, yet state-of- the-art educational opportunity for researchers, clinicians, industry representatives, students/ fellows and patients. NCI funding will be used specifically to augment meeting planning at an early stage for the next several years and to provide opportunities for graduate/medical students and laboratory/clinical fellows to attend the meeting (through travel awards) and to help defray the costs associated with travel of invited experts from outside the Consortium's region and with educational materials (notebooks/slide handouts) used for the meeting. Of great importance to the co-organizers of this Consortium is the inclusion of underrepresented minorities and women in all stages of meeting development, as speakers and as coorganizers, and making sure that the meetings are accessible to all persons, including those with disabilities. In summary, NCI funding for this annual meeting can help to provide for the long-term stability of an important and unique educational opportunity for both cancer researchers and care providers in this region of the country (which includes both underserved rural and urban communities) and contribute greatly toward the NCI's "Roadmap" goal of increased collaboration among regional and comprehensive cancer centers. This consortium has great potential for helping members of this region's cancer centers to network, increase collaborative efforts and pilot innovative approaches in the therapy of cancer, particularly new biological or immunological approaches, which will ultimately benefit patient care and the timely completion of new clinical trials.